(Q34857904)

4 August 2017

1 reference

title

Ultraviolet radiation and tumor immunity. (English)

1 reference

4 August 2017

ultraviolet radiation

1 reference

Frank R de Gruijl

1

1 reference

4 August 2017

1 September 2002

1 reference

4 August 2017

1 reference

4 August 2017

28

1 reference

4 August 2017

122-129

1 reference

4 August 2017

1

1 reference

Longevity of Antigen Presentation and Activation Status of APC Are Decisive Factors in the Balance Between CTL Immunity Versus Tolerance

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Incidence of skin cancer after renal transplantation in The Netherlands.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

UV exposure reduces immunization rates and promotes tolerance to epicutaneous antigens in humans: relationship to dose, CD1a-DR+ epidermal macrophage induction, and Langerhans cell depletion

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

CD11b+ cells and ultraviolet-B-resistant CD1a+ cells in skin of patients with polymorphous light eruption

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Immunologic parameters of ultraviolet carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Systemic alteration induced in mice by ultraviolet light irradiation and its relationship to ultraviolet carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

CD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Helper activity is required for the in vivo generation of cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

In Vivo Triggering Through 4-1BB Enables Th-Independent Priming of CTL in the Presence of an Intact CD28 Costimulatory Pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Immunodominance deters the response to other tumor antigens thereby favoring escape: prevention by vaccination with tumor variants selected with cloned cytolytic T cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Telomerase as a universal tumor-associated antigen for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Pre-existent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Identification of HER-2/neu immunogenic epitopes presented by renal cell carcinoma and other human epithelial tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

p53: a potential target antigen for immunotherapy of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Long lasting p53-specific T cell memory responses in the absence of anti-p53 antibodies in patients with resected primary colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Tumor antigen presentation by dermal antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Differential regulation of epidermal cell tumor-antigen presentation by IL-1alpha and IL-1beta

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Protective immunity to UV radiation-induced skin tumours induced by skin grafts and epidermal cells

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Dendritic epidermal T-cell involvement in induction of CD8+ T cell-mediated immunity against an ultraviolet radiation-induced skin tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Perturbation of epidermal Langerhans cells in immunosuppressed human renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Chemical carcinogens and antigens contribute to cutaneous tumor promotion by depleting epidermal Langerhans cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Progressor but not regressor skin tumours inhibit Langerhans' cell migration from epidermis to local lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

2B4, a new member of the immunoglobulin gene superfamily, is expressed on murine dendritic epidermal T cells and plays a functional role in their killing of skin tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Activation of murine epidermal gamma delta T cells through surface 2B4.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Inhibitory effect of a dendritic epidermal T cell line on K1735 melanoma cells in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Resident skin-specific gammadelta T cells provide local, nonredundant regulation of cutaneous inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Evidence for the generation of suppressor cells by ultraviolet radiation

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Suppressor T Lymphocytes Control the Development of Primary Skin Cancers in Ultraviolet-Irradiated Mice

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

IL-12 prevents the inhibitory effects of cis-urocanic acid on tumor antigen presentation by Langerhans cells: implications for photocarcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Urocanic acid isomers in patients with basal cell carcinoma and cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Sunlight, immunosuppression and skin cancer: role of histamine and mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Communications: high dermal mast cell prevalence is a predisposing factor for basal cell carcinoma in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Evidence for functional relevance of CTLA-4 in ultraviolet-radiation-induced tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Interleukin 12 breaks ultraviolet light induced immunosuppression by affecting CD8+ rather than CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Immune suppression and skin cancer development: regulation by NKT cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

The role of UV-B light in skin carcinogenesis through the analysis of p53 mutations in squamous cell carcinomas of hairless mice

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

1 reference

7 January 2021

Time and dose dependence of acceptance of UV-induced syngeneic tumor implants in chronically UV-exposed hairless mice

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

Loss of resistance to a highly immunogenic tumor with age corresponds to the decline of CD8 T cell activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900200-1

7 January 2021

10.1016/S1046-2023(02)00200-1

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12231196